Tumor aggregates from ovarian cancer patients ascitic fluid present low caspase-3 expression

Authors

  • C. Batista-Pinto IUCS, Instituto Universitário de Ciências da Saúde, CESPU, CRL, 485-116 Gandra, Portugal; TOXRUN – Toxicology Research Unit, University Institute of Health Sciences, CESPU, CRL, 4585-116 Gandra, Portugal
  • A. D. Resende IUCS, Instituto Universitário de Ciências da Saúde, CESPU, CRL, 485-116 Gandra, Portugal; TOXRUN – Toxicology Research Unit, University Institute of Health Sciences, CESPU, CRL, 4585-116 Gandra, Portugal
  • R. Andrade IUCS, Instituto Universitário de Ciências da Saúde, CESPU, CRL, 485-116 Gandra, Portugal
  • F. Garcez IUCS, Instituto Universitário de Ciências da Saúde, CESPU, CRL, 485-116 Gandra, Portugal; UNIPRO – Oral Pathology and Rehabilitation Research Unit, University Institute of Health Sciences, CESPU, CRL, 4585-116 Gandra, Portugal
  • V. Ferreira IPOP – Instituto Português de Oncologia do Porto, Departamento de Patologia, 4200-162 Porto, Portugal
  • C. Lobo IPOP – Instituto Português de Oncologia do Porto, Departamento de Patologia, 4200-162 Porto, Portugal
  • P. Monteiro IPOP – Instituto Português de Oncologia do Porto, Departamento de Patologia, 4200-162 Porto, Portugal
  • M. H. Abreu IPOP – Instituto Português de Oncologia do Porto, Serviço de Oncologia Médica, 4200-162 Porto, Portugal; Porto Comprehensive Cancer Center Raquel Seruca, 4200-162 Porto, Portugal
  • C. Bartosch IPOP – Instituto Português de Oncologia do Porto, Departamento de Patologia, 4200-162 Porto, Portugal; Porto Com-prehensive Cancer Center Raquel Seruca, 4200-162 Porto, Portugal; Grupo Biologia do Cancro & Epigenética, Centro de Investigação do IPOP, 4200-162 Porto, Portugal
  • S. Ricardo IUCS, Instituto Universitário de Ciências da Saúde, CESPU, CRL, 485-116 Gandra, Portugal; TOXRUN – Toxicology Research Unit, University Institute of Health Sciences, CESPU, CRL, 4585-116 Gandra, Portugal; i3S – Institute for Research and Innovation in Health, University of Porto, Differentiation and Cancer Group, 420-135 Porto, Portugal; FMUP – Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal

DOI:

https://doi.org/10.48797/sl.2023.94

Keywords:

Poster

Abstract

Background: Ascites is observed in ovarian cancer advanced stages because of the inflammatory process caused by tumor cells invasion of the peritoneal cavity [1,2]. In the ascitic fluid microenvironment, tumor cells can be found isolated or forming aggregates, being key mediators of transceolomic metastization [1,2]. In vitro multicellular spheroids show anoikis resistance presenting high survival levels when compared to isolated tumor cells [3]. The viability of these tumor cells is crucial for the establishment of patient-derived organoids (PDOs) that constitute a valuable preclinical platform for drug testing [3]. Objective: This study aims to evaluate the tumor cells apoptotic levels (single cells and aggregates) in the ascitic fluid of ovarian cancer patients. Methods: We evaluated 23 cytologic samples from ovarian cancer patients with ascites admitted at IPOPorto under a project approved by IPOPorto ethics committee (CES.092R1/019). Standard histologic processing was performed on the formalin-fixed and Histogel™ embedded ascitic fluid. For the apoptotic cell detection an immunohistochemistry technique with anti-caspase-3 antibody was applied and evaluated by microscopy. Results: During standardization, the ideal primary antibody concentration and incubation time were set, as also the antigenic retrieval procedure was optimized. We included a positive control to validate the technique in each run. Our results show that, in most of the samples, cellular aggregates were negative for caspase-3 expression, >75% of the cells, but some positivity was observed in isolated tumor cells. Conclusions: The evaluation of caspase-3 expression by immunohistochemistry proved to be a reliable methodology to evaluate the apoptotic levels in cytology samples. In general, tumor cells within aggregates showed high viability levels, whereas some isolated tumor cells presented caspase-3 expression, which indicate they are undergoing an apoptotic process. The tumor aggregates high viability in these samples is a good indicator that the establishment of PDOs from these tumor cells will be successful.

References

1. Nunes, D.; Ricardo, S. Ovarian Cancer Ascites as a Liquid Tumor Microenvironment. In Ovarian Cancer [In-ternet]; Lele S., editor; Brisbane (AU): Exon Publications, 2022; Chapter 3.

2. Al Habyan, S.; Kalos, C.; Szymborski, J.; McCaffrey, L. Multicellular detachment generates metastatic spheroids during intra-abdominal dissemination in epithelial ovarian cancer. Oncogene 2018, 37(37), 5127–5135.

3. Nunes, M.; Ricardo, S. Chemoresistance in Ovarian Cancer: The Role of Malignant Ascites. In Ovarian Cancer [Internet]; Lele S., editor; Brisbane (AU): Exon Publications, 2022; Chapter 2.

Downloads

Published

2023-04-21

How to Cite

Batista-Pinto , C., Resende, A. D., Andrade, R., Garcez, F., Ferreira , V., Lobo, C., Monteiro , P., Abreu , M. H., Bartosch, C., & Ricardo , S. (2023). Tumor aggregates from ovarian cancer patients ascitic fluid present low caspase-3 expression . Scientific Letters, 1(Sup 1). https://doi.org/10.48797/sl.2023.94

Issue

Section

Posters

Similar Articles

1 2 3 4 5 6 7 8 9 10 > >> 

You may also start an advanced similarity search for this article.